tiprankstipranks
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (DE:GU5)
FRANKFURT:GU5
Germany Market

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GU5) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

GU5 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Guangzhou
Baiyunshan Pharmaceutical Holdings Company
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GU5 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:GU5 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GU5 Financial Forecast

GU5 Earnings Forecast

The previous quarter’s earnings for GU5 were €0.14.
The previous quarter’s earnings for GU5 were €0.14.

GU5 Sales Forecast

The previous quarter’s earnings for GU5 were €2.91B.
The previous quarter’s earnings for GU5 were €2.91B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on DE:GU5
Unknown Analyst
CICC
Not Ranked
CICC
€2.54
Buy
52.23%
Upside
Reiterated
04/28/26
CICC Sticks to Their Buy Rating for Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF)
Citi Analyst forecast on DE:GU5
Unknown Analyst
Citi
Not Ranked
Citi
€1.6
Sell
-4.03%
Downside
Reiterated
08/27/25
Bank of America Securities Analyst forecast on DE:GU5
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
€2.43
Buy
45.61%
Upside
Reiterated
08/18/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on DE:GU5
Unknown Analyst
CICC
Not Ranked
CICC
€2.54
Buy
52.23%
Upside
Reiterated
04/28/26
CICC Sticks to Their Buy Rating for Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF)
Citi Analyst forecast on DE:GU5
Unknown Analyst
Citi
Not Ranked
Citi
€1.6
Sell
-4.03%
Downside
Reiterated
08/27/25
Bank of America Securities Analyst forecast on DE:GU5
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
€2.43
Buy
45.61%
Upside
Reiterated
08/18/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

GU5 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
1
1
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
0
0
In the current month, GU5 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GU5 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

GU5 Stock Forecast FAQ

What is DE:GU5’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:GU5’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:GU5, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s share price target?
      Currently, no data Available
      What do analysts say about Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?
      To buy shares of DE:GU5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.